4//SEC Filing
Verdine Gregory L. 4
Accession 0000950170-25-035834
CIK 0001631574other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 9:00 PM ET
Size
10.2 KB
Accession
0000950170-25-035834
Insider Transaction Report
Form 4
Verdine Gregory L.
Director
Transactions
- Exercise/Conversion
Share Option (right to buy)
2025-03-05−133,000→ 133,402 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (133,000 underlying) - Exercise/Conversion
Ordinary Shares
2025-03-05$2.48/sh+133,000$329,840→ 179,155 total - Exercise/Conversion
Ordinary Shares
2025-03-07$2.48/sh+133,402$330,837→ 312,517 total - Exercise/Conversion
Share Option (right to buy)
2025-03-07−133,402→ 0 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (133,402 underlying)
Footnotes (1)
- [F1]The share options that were exercised via cash purchase in this reportable transaction were fully vested.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001572315
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 9:00 PM ET
- Size
- 10.2 KB